Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-10-04
2005-10-04
Spivack, Phyllis (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S415000, C514S382000, C514S443000
Reexamination Certificate
active
06951869
ABSTRACT:
A method of preventing or treating either scarring or capsular contractures in subjects in need of such treatment comprising the administration of leukotriene receptor antagonists to said subject in need of treatment.
REFERENCES:
patent: 6649633 (2003-11-01), Chambers et al.
patent: 2001057025 (2001-08-01), None
Chiba et al., Japanese Journal of Plastic and Reconstructive Surgery, 39/6 (587-591) (1996) (abstract).
Accolate Prescribing Information (2001).
Camirand, Andre, MD, et al., “Breast Augmentation: Compression—A Very Important Factor in Preventing Capsular Contracture”, Plast Recons Surg 104(2):529-538 (1999).
Ersck, Robert A, MD, FACS, “Firestrom Fibrosis: The Fast Fibrotic Phenomenon”, Ann. of Plast Surg vol. 26, No. 5, pp. 494-498 (1991).
Collis, Nicholas, B.Sc., FRCS, (Ed.), et al., “Recurrence of Subglandular Breast Implant Capsular Contracture: Anterior versus Total Capsulectomy”, Plast Resonstr Surg 106: 792-797 (2000).
Collis, Nicholas, B.Sc., FRCS, (Ed.), et al., “Ten-Year Review of a Prospective Randomized Controlled Trial of Textured versus Smooth Subglandular Silicone Gel Breast Implants”, Plast Reconstr Surg 106: 786-791 (2000).
Rohrich, Rod J., MD, et al. “Preventing Capsular Contracture in Breast Augmentation: In Search of the Holy Grail”, Plast Reconstr Surg 103: 1759-1760 (1999).
Netscher, David, MD, “Discussion: Optimizing Breast Pocket Irrigation: An in Vitro Study and Clinical Implications”, Plast Reconstr Surg 105: 339-341 (2000).
Becker, Hilton, MD, et al., “Prevention of Capsular Contracture”, Plast Reconstr Surg 103: 1766-1768 (1999).
Burkhardt, Boyd R., MD, “Prevention of Capsular Contracture”, Plast Reconstr Surg 103: 1769-1772 (1999).
Mladick, Richard A., MD, “Prevention of Capsular Contracture”, Plast Reconstr Surg 103: 1773-1774 (1999).
Miller III, Archibald S., MS, MD, et al., “Alteration of Fibrous Capsule Formation by Use of Immunomodulation”, Aesth Surg J Online, vol. 18, No. 5, pp. 1-10 (1998).
Bernstein, Peter R., “Chemistry and Structure-Activity Relationships of Leukotriene Receptor Antagonists”, Am J Respir Crit Care Med, vol. 157, pp. S220-S226 (1998).
Calhoun, William J., “Summary of Clinical Trials with Zafirlukast”, Am J Respir Crit Care Med, vol. 157, pp. S238-S246 (1998).
Smith, Lewis, J., MD, et al., “A single dose of zafirlukast reduces LTD4-induced bronchoconstriction in patients on maintenance inhaled corticosteroid therapy”, Ann Allergy Asthma Immunol 81: 43-49 (1998).
Kelloway, Judy S., Pharma D, et al., “Comparison of Patients' Compliance with Prescribed Oral and Inhaled Asthma Medications”, Arch Intern Med. 154: 1349-1352 (1994).
Virchow, Jr., J. Christian, et al., “Zafirlukast Improves Asthma Control in Patients Receiving High-Dose Inhaled Corticosteroids”, Am J Respir Crit Care Med 162: 578-585 (2000).
Ko, Clifford Y., MD, et al., “Capsular Synovial Metaplasia as a Common Response to Both Textured and Smooth Implants”, Plast Reconstr Surg, vol. 97, No. 7, pp. 1427-1433 (1996).
Raso, Dominic S., MD, et al., “Immunolocalization of Keratan Sulfate, Chondroitin-4-Sulfate, and Chondroitin-6-Sulfate in Periprosthetic Breast Capsules Exhibiting Synovial Metaplasia”, Plast Reconstr Surg, vol. 98, No. 1, pp. 78-82 (1996).
Niessen, Frank B., MD, et al., “On the Nature of Hypertrophic Scars and Keloids: A Review”, Plast Reconstr Surg 104(5): 1435-1458 (1999).
Baker, Jr., James L., MD, et al., “Occurrence and Activity of Myofibroblasts in Human Capsular Tissue Surrounding Mammary Implants”, Plast Reconstr Surg, vol. 68, pp. 905-911 (1981).
Drazen, Jeffrey, “Clinical Pharmacology of Leukotriene Receptor Antagonists and 5-Lipoxygenase Inhibitors”, Am J Respir Crit Care Med, vol. 157, pp. S233-S237 (1998).
Peters-Golden, Marc, “Cell Biology of the 5-Lipoxygenase Pathway”, Am J Respir Crit Care Med, vol. 157, pp. S227-S232 (1998).
Vistnes, Lars M., et al., “Tissue Response to Soft Silicone Prostheses: Capsule Formation and Other Sequelae”, Biomaterials in Plastic Surgery, chap. 33, pp. 516-528 dated (1983).
LandOfFree
Use of leukotriene receptor antagonist for treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of leukotriene receptor antagonist for treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of leukotriene receptor antagonist for treatment of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3488727